Hohmann, Christopher
Michels, Guido
Schmidt, Matthias
Pfister, Roman
Mader, Navid
Ohler, Myriam
Blanke, Lara
Jazmati, Nathalie
Lehmann, Clara
Rybniker, Jan
Fünger, Sarah M.
Fätkenheuer, Gerd
Jung, Norma
Article History
Received: 4 November 2018
Accepted: 4 February 2019
First Online: 13 February 2019
Compliance with ethical standards
:
: C.H. reports personal fees from MSD Sharp & Dohme and Pfizer, lecture fees from Actelion and travel grants from Actelion, Bayer, Orion Pharma and MSD Sharp & Dohme. G.M. received lecture fees from Pfizer, Novartis, Servier, ZOLL, Getinge and Orion Pharma. In the past 3 years, N. Jazmati has received payment for lectures from MSD Sharp & Dohme. C.L. has received honoraria for lectures or travel grants from Abbott, ViiV, Gilead, MSD, and Janssen. In the past 2 years, G.F. has received lecture fees from Bristol Myers Squibb, Janssen Cilag, Merck Sharp & Dohme and Pfizer, travel grants from Gilead and Janssen Cilag, research grants from Gilead, Janssen Cilag, Merck Sharp & Dohme and Roche. G.F. served on advisory boards of Janssen Cilag, Merck Sharp & Dohme, Merck Serono, Pfizer, Roche and Shionogi. In the last 3 years, N. Jung has received lecture fees from Labor Stein, Novartis, Gilead, Infectopharm and MSD and travel grants from Gilead, Novartis and Basilea.